Many are responding and investing millions to expand capacity for this promising new class.

Emerging class of therapeutics represents a coming wave for developers and manufacturers

By American Chemical Society —— Bio and Archives--January 22, 2014

Health and Medicine | Comments | Back To Full Article

After years of research, development and testing, a new class of drugs is emerging on the market with two frontrunners acting as harbingers of what’s to come. The cover story in Chemical & Engineering News, ACS’ weekly newsmagazine, explores the potential of these antibody-drug conjugates (ADCs) and the challenges in developing and manufacturing them.

Read Full Article...

Welcome to CFP’s Comment Section!

The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.

Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.

Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.

We ask only that commenters keep it civil, keep it clean.

Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.

READ OUR Commenting Policy

CFP Comments

Comments

Support Canada Free Press

Recommended by Canada Free Press